Related Experiment Video

Updated: May 27, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

Predicting heart failure outcome from cardiac and comorbid conditions: the 3C-HF score

Michele Senni1, Piervirgilio Parrella, Renata De Maria

  • 1Dipartimento Cardiovascolare - Dipartimento Medicina Interna, Ospedali Riuniti, Bergamo, Italy. msenni@ospedaliriuniti.bergamo.it

International Journal of Cardiology
|December 2, 2011
PubMed

Insights

A new Cardiac and Comorbid Conditions Heart Failure (3C-HF) Score effectively predicts 1-year mortality in heart failure patients using routine clinical data. This simple tool aids in better prognostic stratification for improved patient management.

Area of Science:

  • Cardiology
  • Clinical Epidemiology
  • Health Outcomes Research

Background:

  • Prognostic stratification is vital for heart failure (HF) management.
  • Existing HF outcome prediction models have limitations.
  • A need exists for simple, accurate risk assessment tools in HF.

Purpose of the Study:

  • To develop and validate a simple risk stratification model for predicting 1-year all-cause mortality in HF patients.
  • To create the Cardiac and Comorbid Conditions HF (3C-HF) Score using routinely available clinical data.

Main Methods:

  • A cohort study of 6274 HF patients across 24 European centers.
  • Data from 2016 patients used for model derivation and 4258 for validation.
  • Multivariable analysis of cardiac and comorbid predictors for 1-year mortality.

Main Results:

  • Key predictors included NYHA class III-IV, low LVEF, medication non-use, comorbidities (diabetes, renal dysfunction, hypertension), and atrial fibrillation.
  • The 3C-HF score achieved a C-statistic of 0.87 (derivation) and 0.82 (validation) for 1-year mortality.
  • 12.1% of patients experienced all-cause death or urgent transplantation during follow-up.

Conclusions:

  • The 3C-HF score is a simple, valuable tool for prognostic stratification in HF.
  • It utilizes easily obtainable cardiac and comorbid conditions.
  • Applicable to daily clinical practice for improved HF patient management.
Abstract

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...